AMBU B Ambu A/S Class B

Proposed changes within Ambu’s Board of Directors

Proposed changes within Ambu’s Board of Directors

Ambu’s Board of Directors proposes the election of two new members – Susanne Larsson and Michael del Prado – at the annual general meeting in December 2021.

Ambu A/S announces today that the Board of Directors will propose that Susanne Larsson, CFO at Mölnlycke, and Michael del Prado, former Company Group Chairman of Johnson & Johnson Medical Devices, are elected as new members of the Board of Directors at the annual general meeting on 14 December 2021.

Jørgen Jensen, chairman of the Board of Directors, comments on the new candidates: “I’m excited that we can strengthen Ambu’s Board of Directors with Susanne Larsson and Michael del Prado who are both global diverse leaders with extensive knowledge and experience from major healthcare companies. I’m certain that they will be able to contribute effectively to our accelerated growth journey as the world’s most innovative single-use endoscope company.

Susanne Larsson is Group Chief Financial Officer at Mölnlycke – a global medtech provider of single-use surgical and wound care products. She has a strong track record of financial leadership in publicly listed companies with more than a decade of CFO, strategy, and business development experience. Susanne Larsson lives in Gothenburg and is a Swedish national.

Michael del Prado has had a distinctive executive career in Johnson & Johnson across the USA, Asia Pacific and Europe including leading Ethicon – the world’s largest surgery company with over DKK 50b in sales. He has a track record of building businesses globally and driving innovation and technology agendas. Michael del Prado lives in Pennsylvania, USA, and holds a dual citizenship of the USA and the Philippines.

Mikael Worning, who has been a member of the Board of Directors in Ambu A/S since 2010, has decided not to seek re election at the annual general meeting. “Over the last decade, Mikael Worning has contributed effectively to the development of Ambu – including serving as vice-chairman – and on behalf of the entire Board of Directors I would like to thank him for his efforts, dedication and contribution to building Ambu into the company it is today,” says Jørgen Jensen.

With the proposed changes, Ambu’s Board of Directors will be expanded from five to six members elected at the annual general meeting.

CONTACTS

Investors

Nicolai Thomsen, Director, Investor Relations & Strategic Financial Planning, /

Media

Mikkel Trier Wagner, Director, Corporate Communications, /

Attachment



EN
17/08/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ambu A/S Class B

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen

Ambu AS: 1 director

A director at Ambu AS bought 10,500 shares at 82.900DKK and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showi...

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen

ResearchPool Subscriptions

Get the most out of your insights

Get in touch